Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluation of QTc Interval”

165 trials

Showing 20 of 165 results

Early research (Phase 1)Study completedNCT07063238
What this trial is testing

A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT05924321
What this trial is testing

Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

Who this might be right for
Postpartum Hemorrhage
Ferring Pharmaceuticals 40
Early research (Phase 1)Not Yet RecruitingNCT06591845
What this trial is testing

Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

Who this might be right for
Healthy Volunteers
Shanghai Ark Biopharmaceutical Co., Ltd. 32
Early research (Phase 1)Study completedNCT01103830
What this trial is testing

Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers

Who this might be right for
Malaria, Falciparum
sigma-tau i.f.r. S.p.A. 287
Early research (Phase 1)Study completedNCT01423916
What this trial is testing

Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 218
Early research (Phase 1)Study completedNCT01210846
What this trial is testing

A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AVEO Pharmaceuticals, Inc. 50
Very early researchStudy completedNCT04966325
What this trial is testing

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

Who this might be right for
HyperuricemiaGoutQt Interval, Variation in
LG Chem 37
Post-approval studies (Phase 4)Study completedNCT01860703
What this trial is testing

Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects

Who this might be right for
Prolonged QTc Interval
ApoPharma 50
Early research (Phase 1)Study completedNCT07378579
What this trial is testing

An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001

Who this might be right for
Healthy Volunteer
Alumis Inc 52
Early research (Phase 1)Study completedNCT00964730
What this trial is testing

Investigate the Effects of Talampanel on the Heart Rhythm

Who this might be right for
Healthy
Teva Branded Pharmaceutical Products R&D, Inc. 135
Early research (Phase 1)Active Not RecruitingNCT07266818
What this trial is testing

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Study completedNCT03565068
What this trial is testing

A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 75
Early research (Phase 1)WithdrawnNCT01039610
What this trial is testing

A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.

Who this might be right for
Infections, Bacterial
GlaxoSmithKline
Early research (Phase 1)Study completedNCT05924815
What this trial is testing

Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval

Who this might be right for
Healthy Participants
Cytokinetics 44
Early research (Phase 1)WithdrawnNCT05309902
What this trial is testing

Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

Who this might be right for
Healthy Volunteers
Takeda
Early research (Phase 1)Not Yet RecruitingNCT06543459
What this trial is testing

To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Wuhan Createrna Science and Technology Co., Ltd 16
Early research (Phase 1)Study completedNCT03504982
What this trial is testing

Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

Who this might be right for
Coronary Artery Disease
Bayer 74
Early research (Phase 1)Study completedNCT01269294
What this trial is testing

TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 60
Post-approval studies (Phase 4)WithdrawnNCT04088266
What this trial is testing

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Who this might be right for
Evaluation of QTc Interval
Teva Pharmaceuticals USA
Early research (Phase 1)Study completedNCT02910635
What this trial is testing

Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

Who this might be right for
Abnormalities, Cardiovascular
Ionis Pharmaceuticals, Inc. 52
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation